Reflux Pharmaceuticals Private Limited, a active private limited company, was established on 03 February 2020 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999MH2020PTC337046. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹7.68 M.
It upholds a compliant status. Its leadership includes Jaid Ismail Kojar (Nominee Director), Amit Kumar Ghosh (Director), Sandeep Khandu Tekle (Director). It holds ₹8.50 Cr open charges and ₹5.18 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Gala No. 83, 3Rd Floor, C-39/A, Gami Industrial Park, Ttc Industrial Area, Midc Pavane, Thane, Maharashtra, 400705.
U74999MH2020PTC337046
337046
03 February 2020
₹5.00 Cr
₹7.68 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Reflux Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jaid Ismail Kojar | Nominee Director | 29 Jul 2024 | Current |
| Amit Kumar Ghosh | Director | 03 Feb 2020 | Current |
| Sandeep Khandu Tekle | Director | 03 Feb 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Reflux Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 386.06% increase. The company also saw a slight decrease in profitability, with a 5.71% decrease in profit. The company's net worth Soared by an impressive increase of 91.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Reflux Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹85,000,000.00
₹51,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2023 | Others | ₹8.50 Cr | Open |
| 17 Mar 2022 | Others | ₹5.18 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Reflux Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Reflux Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reflux Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Reflux Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Jaid Ismail Kojar was appointed as a Nominee Director was appointed as a Nominee Director on 29 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
The activity Reflux Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge registered on 17 Mar 2022 via Charge ID 100587794 with Others was fully satisfied on 10 Aug 2023. was completed.
Progress on A charge with Others of Rs. 8.50 Cr registered on 09 Mar 2023 with Charge ID 100701436 was modified on 16 Jun 2023. was documented.
A charge with Others amounted to Rs. 8.50 Cr with Charge ID 100701436 was registered on 09 Mar 2023. was recorded as a recent event.
The CIN of Reflux Pharmaceuticals Private Limited is U74999MH2020PTC337046.
Reflux Pharmaceuticals Private Limited is headquartered at Gala No. 83, 3Rd Floor, C-39/A, Gami Industrial Park, Ttc Industrial Area, Midc Pavane, Thane, Maharashtra, 400705.
Reflux Pharmaceuticals Private Limited was incorporated on 03 February 2020.
The current directors of Reflux Pharmaceuticals Private Limited are
The primary industry of Reflux Pharmaceuticals Private Limited is Manufacturing.
Reflux Pharmaceuticals Private Limited is unlisted.
The authorized capital of Reflux Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹7.68 M.
The compliance status of Reflux Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX